Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6TT0

Crystal structure of a potent and reversible dual binding site Acetylcholinesterase chiral inhibitor

Summary for 6TT0
Entry DOI10.2210/pdb6tt0/pdb
DescriptorAcetylcholinesterase, (1~{R},3~{S})-~{N}-(6,7-dimethoxy-2-oxidanylidene-chromen-3-yl)-3-[(phenylmethyl)amino]cyclohexane-1-carboxamide, 2-acetamido-2-deoxy-beta-D-glucopyranose, ... (4 entities in total)
Functional Keywordsdual binding site inhibitor, chiral separation, acetylcholinesterase, alzheimer's disease, hydrolase
Biological sourceTetronarce californica (Pacific electric ray)
Total number of polymer chains1
Total formula weight66194.51
Authors
de la Mora, E.,Mangiatordi, G.F.,Belviso, B.D.,Caliandro, R.,Colletier, J.P.,Catto, M. (deposition date: 2019-12-22, release date: 2020-06-10, Last modification date: 2024-11-20)
Primary citationCatto, M.,Pisani, L.,de la Mora, E.,Belviso, B.D.,Mangiatordi, G.F.,Pinto, A.,Palma, A.,Denora, N.,Caliandro, R.,Colletier, J.P.,Silman, I.,Nicolotti, O.,Altomare, C.D.
Chiral Separation, X-ray Structure, and Biological Evaluation of a Potent and Reversible Dual Binding Site AChE Inhibitor.
Acs Med.Chem.Lett., 11:869-876, 2020
Cited by
PubMed Abstract: Acetylcholinesterase (AChE) inhibitors (AChEIs) still remain the leading therapeutic options for the symptomatic treatment of cognitive deficits associated with mild-to-moderate Alzheimer's disease. The search for new AChEIs benefits from well-established knowledge of the molecular interactions of selective AChEIs, such as donepezil and related dual binding site inhibitors. Starting from a previously disclosed coumarin-based inhibitor (±)--, active as racemate in the nanomolar range toward AChE, we proceeded on a double track by (i) achieving chiral resolution of the enantiomers of by HPLC and (ii) preparing two close achiral analogues of , i.e., compounds and . An eudismic ratio as high as 20 was observed for the (-) enantiomer of -. The X-ray crystal structure of the complex between the (-)-- eutomer (coded as ) and AChE was determined at 2.8 Å, and docking calculation results suggested that the eutomer in (1,3) absolute configuration should be energetically more favored in binding the enzyme than the eutomer in (1,3) configuration. The achiral analogues and were less effective in inhibiting AChE compared to (±)--, but interestingly butylamide emerged as a potent inhibitor of butyrylcholinesterase (BChE).
PubMed: 32435398
DOI: 10.1021/acsmedchemlett.9b00656
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.80003021833 Å)
Structure validation

246031

数据于2025-12-10公开中

PDB statisticsPDBj update infoContact PDBjnumon